Real-World Biologic Use Patterns in Severe Asthma, 2015-2021: The CLEAR Study
{{output}}
Background: Biologics targeting immunoglobulin E, interleukin (IL)-4/IL-13 or IL-5 signaling are effective at treating severe asthma; however, individual patients' responses may be suboptimal, leading to therapy switching or sto... ...
